Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.3016
-0.0048 (-1.57%)
At close: May 15, 2026, 4:00 PM EDT
0.3070
+0.0054 (1.79%)
After-hours: May 15, 2026, 7:59 PM EDT
Cosmos Health Employees
Cosmos Health had 163 employees as of December 31, 2025. The number of employees increased by 14 or 9.40% compared to the previous year.
Employees
163
Change (1Y)
14
Growth (1Y)
9.40%
Revenue / Employee
$400,441
Profits / Employee
-$117,454
Market Cap
15.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 163 | 14 | 9.40% |
| Dec 31, 2024 | 149 | 26 | 21.14% |
| Dec 31, 2023 | 123 | 21 | 20.59% |
| Dec 31, 2022 | 102 | 7 | 7.37% |
| Dec 31, 2021 | 95 | 6 | 6.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cardinal Health | 57,700 |
| Cencora | 51,000 |
| McKesson | 43,000 |
| Henry Schein | 25,000 |
| Accendra Health | 6,500 |
| 111, Inc. | 1,238 |
| EDAP TMS | 310 |
| Synergy CHC | 28 |
COSM News
- 1 day ago - Cosmos Health pursues research, development financing program with EIB - TheFly
- 1 day ago - Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program - Accesswire
- 3 days ago - Cosmos Health announces withdrawal of registration statement on Form S-1 - TheFly
- 3 days ago - Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - Accesswire
- 4 days ago - Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - Accesswire
- 7 days ago - Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - Accesswire
- 15 days ago - Cosmos Health sees over $2.5M incremental annual revenue from Cur18 in U.S. - TheFly
- 15 days ago - Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - Accesswire